Dr Franco Locatelli Discusses the Treatment of Patients with cGvHD
July 21st 2023Franco Locatelli, MD, PhD, head of the Department of Pediatric Hematology and Oncology at IRCCS Bambino Gesu Children’s Hospital in Rome, discusses the treatment of both adult and pediatric patients with chronic graft versus host disease (cGvHD).
Dr Franco Locatelli: Assessing Ruxolitinib Treatment in Pediatric Patients With cGvHD
July 14th 2023Franco Locatelli, MD, PhD, a professor and hematologist from Italy, discusses results from the the phase 2 REACH 5 studies assessing the use of ruxolitinib in pediatric patients with chronic graft versus host disease (cGvHD).
Texas Oncology's Sydney Townsend Spotlights Mental Health in Cancer Care Journey
July 14th 2023Sydney Townsend, executive director of digital health at Texas Oncology, explains how cancer diagnosis and treatment can impact a patient’s mental well-being and how she assesses a patient’s overall cancer care experience.
Standardized SIF Reporting, Management Guidelines Needed in LDCT Lung Screening
July 12th 2023A retrospective case series study suggests that standardized guidelines for reporting and managing significant incidental findings (SIFs) in low-dose computed tomography (LDCT) lung cancer screening could help optimize the treatment of patients whose LDCT scans show SIFs.
Study Highlights Uneven Symptom Burden in Patients With Uncontrolled vs Controlled Severe Asthma
July 10th 2023An analysis found that patients with uncontrolled severe asthma have a higher symptom burden compared with those whose severe asthma is controlled, highlighting the need for more innovative treatment options to improve asthma control.
Dr Melinda Gooderham: Emerging vs Traditional Therapies for Patients With Atopic Dermatitis
July 6th 2023Melinda Gooderham, MD, MSc, FRCPC, Peterborough Regional Health Centre in Ontario, Canada, breaks down which subgroup of patients with atopic dermatitis (AD) may benefit the most from emerging therapies, as well as the advantages and disadvantages of these therapies.
Travis Brewer Discusses Payer Initiatives to Improve Oncology Patient Outcomes
June 27th 2023Texas Oncology's Travis Brewer, vice president of payer relations, discusses how collaboration between primary care providers and oncologists can improve population health outcomes by focusing on payer initiatives and strategies.